• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于可生物降解纳米聚合物的眼部药物递送研究进展

Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.

作者信息

Lynch Courtney, Kondiah Pierre P D, Choonara Yahya E, du Toit Lisa C, Ally Naseer, Pillay Viness

机构信息

Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown 2193, South Africa.

Division of Ophthalmology, Department of Neurosciences, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown 2193, South Africa.

出版信息

Polymers (Basel). 2019 Aug 20;11(8):1371. doi: 10.3390/polym11081371.

DOI:10.3390/polym11081371
PMID:31434273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6722735/
Abstract

The effective delivery of drugs to the eye remains a challenge. The eye has a myriad of defense systems and physiological barriers that leaves ocular drug delivery systems with low bioavailability profiles. This is mainly due to poor permeability through the epithelia and rapid clearance from the eye following administration. However, recent advances in both polymeric drug delivery and biomedical nanotechnology have allowed for improvements to be made in the treatment of ocular conditions. The employment of biodegradable polymers in ocular formulations has led to improved retention time, greater bioavailability and controlled release through mucoadhesion to the epithelia in the eye, amongst other beneficial properties. Nanotechnology has been largely investigated for uses in the medical field, ranging from diagnosis of disease to treatment. The nanoscale of these developing drug delivery systems has helped to improve the penetration of drugs through the various ocular barriers, thus improving bioavailability. This review will highlight the physiological barriers encountered in the eye, current conventional treatment methods as well as how polymeric drug delivery and nanotechnology can be employed to optimize drug penetration to both the anterior and posterior segment of the eye.

摘要

将药物有效递送至眼部仍然是一项挑战。眼睛拥有众多防御系统和生理屏障,这使得眼部药物递送系统的生物利用度较低。这主要是由于药物透过上皮的渗透性差以及给药后从眼部快速清除。然而,聚合物药物递送和生物医学纳米技术的最新进展使得眼部疾病的治疗得以改进。在眼部制剂中使用可生物降解聚合物已带来了更长的保留时间、更高的生物利用度以及通过与眼部上皮的粘膜粘附实现控释等其他有益特性。纳米技术在医学领域已得到广泛研究,涵盖从疾病诊断到治疗等多个方面。这些不断发展的药物递送系统的纳米尺度有助于提高药物透过各种眼部屏障的渗透率,从而提高生物利用度。本综述将重点介绍眼部遇到的生理屏障、当前的传统治疗方法,以及如何利用聚合物药物递送和纳米技术来优化药物对眼前段和眼后段的渗透。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/b3815645b926/polymers-11-01371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/d0f44a1e6b14/polymers-11-01371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/5291be97cbdc/polymers-11-01371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/4fc8dd157677/polymers-11-01371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/83b1443d9feb/polymers-11-01371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/3a458fb44ff4/polymers-11-01371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/b3815645b926/polymers-11-01371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/d0f44a1e6b14/polymers-11-01371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/5291be97cbdc/polymers-11-01371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/4fc8dd157677/polymers-11-01371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/83b1443d9feb/polymers-11-01371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/3a458fb44ff4/polymers-11-01371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea32/6722735/b3815645b926/polymers-11-01371-g006.jpg

相似文献

1
Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.基于可生物降解纳米聚合物的眼部药物递送研究进展
Polymers (Basel). 2019 Aug 20;11(8):1371. doi: 10.3390/polym11081371.
2
Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.眼部治疗的突破:用于眼前节疾病和青光眼的基于聚合物纳米的药物递送系统
Polymers (Basel). 2023 Mar 9;15(6):1373. doi: 10.3390/polym15061373.
3
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.用于治疗眼前节眼部疾病的基于纳米技术的药物递送系统。
J Control Release. 2023 Feb;354:465-488. doi: 10.1016/j.jconrel.2023.01.018. Epub 2023 Jan 19.
4
Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.基于可生物降解聚合物的眼部疾病药物传递系统。
Int J Mol Sci. 2023 Aug 19;24(16):12976. doi: 10.3390/ijms241612976.
5
Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.利用可生物降解的纳米药物递送系统克服后段疾病的治疗挑战
Pharmaceutics. 2023 Mar 29;15(4):1094. doi: 10.3390/pharmaceutics15041094.
6
Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.乳铁蛋白递送系统的开发、优化及临床相关性:聚焦眼部递送
Pharmaceutics. 2024 Jun 14;16(6):804. doi: 10.3390/pharmaceutics16060804.
7
Recent advances in topical nano drug-delivery systems for the anterior ocular segment.眼前节局部纳米药物递送系统的最新进展
Ther Deliv. 2018 Feb;9(2):137-153. doi: 10.4155/tde-2017-0088.
8
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.眼部药物传递:可降解聚合物纳米载体在眼科应用中的作用。
Int J Mol Sci. 2018 Sep 19;19(9):2830. doi: 10.3390/ijms19092830.
9
Ocular drug delivery to the anterior segment using nanocarriers: A mucoadhesive/mucopenetrative perspective.利用纳米载体实现前节段眼部药物传递:黏膜黏附/黏膜渗透视角。
J Control Release. 2021 Aug 10;336:71-88. doi: 10.1016/j.jconrel.2021.06.011. Epub 2021 Jun 10.
10
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases.基于纳米技术的眼药水:眼部疾病的局部和非侵入性治疗。
Adv Drug Deliv Rev. 2023 Mar;194:114721. doi: 10.1016/j.addr.2023.114721. Epub 2023 Feb 10.

引用本文的文献

1
Microneedles for controlled and sustained intraocular drug delivery.用于眼内药物控释和持续给药的微针
NPG Asia Mater. 2025;17(1):33. doi: 10.1038/s41427-025-00614-7. Epub 2025 Aug 22.
2
Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges.白藜芦醇作为糖尿病视网膜病变的一种新型治疗方法:分子机制、临床潜力及未来挑战
Molecules. 2025 Aug 4;30(15):3262. doi: 10.3390/molecules30153262.
3
Synthesis and Physiochemical Properties of Sulphated Tamarind ( L.) Seed Polysaccharide.

本文引用的文献

1
Synthesis, characterization and in vitro cytocompatibility studies of chitin nanogels for biomedical applications.用于生物医学应用的几丁质纳米凝胶的合成、表征及体外细胞相容性研究
Carbohydr Polym. 2012 Jan 4;87(1):943-949. doi: 10.1016/j.carbpol.2011.08.044. Epub 2011 Aug 24.
2
Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles.通过局部滴注聚乳酸-羟基乙酸共聚物纳米颗粒将药物递送至眼后段的可行性。
Asian J Pharm Sci. 2017 Jul;12(4):394-399. doi: 10.1016/j.ajps.2017.03.002. Epub 2017 Apr 6.
3
Effect of a Cationic Surfactant on Microemulsion Globules and Drug Release from Hydrogel Contact Lenses.
硫酸化罗望子(L.)种子多糖的合成及其理化性质
Molecules. 2024 Nov 21;29(23):5510. doi: 10.3390/molecules29235510.
4
Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.用于治疗视网膜和脉络膜疾病的新型眼内给药平台
J Vitreoretin Dis. 2024 Aug 22;8(5):577-586. doi: 10.1177/24741264241267065. eCollection 2024 Sep-Oct.
5
Nanomedicine in glaucoma treatment; Current challenges and future perspectives.青光眼治疗中的纳米医学:当前挑战与未来展望。
Mater Today Bio. 2024 Sep 4;28:101229. doi: 10.1016/j.mtbio.2024.101229. eCollection 2024 Oct.
6
Development and Characterization of Thermosensitive and Bioadhesive Ophthalmic Formulations Containing Flurbiprofen Solid Dispersions.含氟比洛芬固体分散体的热敏性和生物黏附性眼用制剂的研制与表征
Gels. 2024 Apr 15;10(4):267. doi: 10.3390/gels10040267.
7
Current Advances in Regenerative Strategies for Dry Eye Diseases: A Comprehensive Review.干眼症再生策略的当前进展:全面综述
Bioengineering (Basel). 2023 Dec 29;11(1):39. doi: 10.3390/bioengineering11010039.
8
Development and Bioactivity of Zinc Sulfate Cross-Linked Polysaccharide Delivery System of Dexamethasone Phosphate.地塞米松磷酸酯硫酸锌交联多糖递送系统的研发与生物活性
Pharmaceutics. 2023 Sep 28;15(10):2396. doi: 10.3390/pharmaceutics15102396.
9
Nanostructured Lipid Carriers Mediated Drug Delivery to Posterior Segment of Eye and their Successes.纳米结构脂质载体介导药物递送至眼部后节及其成功应用。
Curr Pharm Biotechnol. 2024;25(6):713-723. doi: 10.2174/1389201025666230907145019.
10
Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.基于可生物降解聚合物的眼部疾病药物传递系统。
Int J Mol Sci. 2023 Aug 19;24(16):12976. doi: 10.3390/ijms241612976.
阳离子表面活性剂对微乳液小球及水凝胶隐形眼镜药物释放的影响。
Pharmaceutics. 2019 Jun 6;11(6):262. doi: 10.3390/pharmaceutics11060262.
4
Recent advances in intraocular sustained-release drug delivery devices.近期眼内缓释药物输送装置的进展。
Drug Discov Today. 2019 Aug;24(8):1694-1700. doi: 10.1016/j.drudis.2019.05.031. Epub 2019 Jun 4.
5
Dual-Responsive Alginate Hydrogels for Controlled Release of Therapeutics.双重响应性海藻酸盐水凝胶用于治疗药物的控制释放。
Molecules. 2019 May 31;24(11):2089. doi: 10.3390/molecules24112089.
6
Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment.混合脂质体/羟丙基甲基纤维素系统中的渗透保护剂作为青光眼的潜在治疗方法
Polymers (Basel). 2019 May 28;11(6):929. doi: 10.3390/polym11060929.
7
Corrigendum to "Overcoming ocular drug delivery barriers through the use of physical forces" [Advanced Drug Delivery Reviews 126 (2018) 96-112].《通过物理力克服眼部药物递送障碍》的勘误 [《高级药物递送评论》126 (2018) 96 - 112]
Adv Drug Deliv Rev. 2019 Jan 15;139:157. doi: 10.1016/j.addr.2019.05.006. Epub 2019 May 24.
8
Therapeutic implications of nanomedicine for ocular drug delivery.纳米医学对眼部药物输送的治疗意义。
Drug Discov Today. 2019 Aug;24(8):1524-1538. doi: 10.1016/j.drudis.2019.05.006. Epub 2019 May 15.
9
Cyclodextrin⁻Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin.用于纳他霉素眼部递送的环糊精-两亲性共聚物超分子组装体
Nanomaterials (Basel). 2019 May 15;9(5):745. doi: 10.3390/nano9050745.
10
Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery: Prolonged ocular retention, enhanced corneal permeation and improved tear production.阳离子化透明质酸涂层隐形眼镜用于环孢素 A 的眼部给药:延长眼部滞留时间、增强角膜渗透和改善泪液生成。
Int J Pharm. 2019 Jun 30;565:133-142. doi: 10.1016/j.ijpharm.2019.05.018. Epub 2019 May 8.